The Efficacy of the IUrisure for Detection of Recurrent Urothelial Carcinoma
Unknown
148 enrolled
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Phase 1 Unknown
77 enrolled
VUBAR
Phase 2 Unknown
55 enrolled
Efficacy and Utility of Cxbladder Tests in Hematuria Patients
Unknown
684 enrolled
JIVAN
Phase 1 Unknown
30 enrolled
18F-LN1 PET/CT in Urothelial Carcinomas
Unknown
30 enrolled
VESUVIO
Unknown
350 enrolled
Safety and Efficacy Study of QLF31907 in Advanced Melanoma and Urothelial Carcinoma
Phase 2 Unknown
66 enrolled
RADIANT
Phase 2 Unknown
16 enrolled
A Study to Evaluate the Safety and Efficacy of AZD4547 Combination With Tislelizumab in Patients With mUC
Phase 2 Unknown
80 enrolled
A Study of ICP-192 in Patients With Advanced Solid Tumors
Phase 1/2 Unknown
45 enrolled
REGOMUNE
Phase 1/2 Unknown
747 enrolled
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma
Phase 4 Unknown
36 enrolled
Perioperative Tislelizumab Combined With Nab-Paclitaxel for Muscle-invasive Urothelial Bladder Carcinoma
Phase 2 Unknown
48 enrolled
A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder
Unknown
50 enrolled
Famitinib Plus Anti-PD1 Therapy for Advanced Urinary System Tumor, Advanced Gynecological Tumors
Phase 2 Unknown
265 enrolled
Multimodal Spectroscopy to Detect Urothelial Cancer in Urine
Unknown
500 enrolled
Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic
Unknown
200 enrolled
The Effectiveness and Safety of Intravesical Gemcitabine Instillation to Prevent Intravesical Recurrence
Phase 2 Unknown
134 enrolled
A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma
Phase 2 Unknown
30 enrolled
Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma
Phase 2 Unknown
19 enrolled
Neoadjuvant Dose Dense MVAC in MIBC and Locally Advanced Urothelial Carcinoma
Phase 2 Unknown
32 enrolled
A Study of MRG002 in the Treatment of HER2-positive Unresectable Locally Advanced or Metastatic Urothelium Cancer
Phase 2 Unknown
58 enrolled
TITAN-TCC
Phase 2 Unknown
169 enrolled
A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547
Phase 1/2 Unknown
108 enrolled
A Prospective, Multi-centre, Single-blinded Study of UroCAD for Urothelial Carcinoma Diagnosis and Follow-up
Unknown
500 enrolled
UroCAD Assay Combined With Computed Tomography Urography and Urine Cytology for UTUC Diagnosis.
Unknown
110 enrolled
Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
Phase 2 Unknown
53 enrolled
A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors
Phase 1 Unknown
156 enrolled
A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients
Phase 2 Unknown
20 enrolled
PIONEER
Unknown
1,000 enrolled
A Study on Toripalimab Plus Nab-Paclitaxel With or Without Cisplatin as First-line Treatment of Urothelial Carcinoma
Phase 2 Unknown
30 enrolled
A Study Evaluating Toripalimab Injection Combined With Standard Chemotherapy as a First-line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma
Phase 3 Unknown
364 enrolled
Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.
Phase 2 Unknown
40 enrolled
Vasculogenic Mimicry in Urothelial Carcinoma
Unknown
70 enrolled
A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer
Phase 1/2 Unknown
36 enrolled
Exercise-based Pre-habilitation in Bladder Cancer Patients Prior to Radical Cystectomy: a Feasibility Study
Phase NA Unknown
20 enrolled
Application of UCAD for Diagnosing Urothelial Carcinoma.
Unknown
300 enrolled
Paclitaxel and TAK-228 in Urothelial Carcinoma
Phase 2 Unknown
52 enrolled
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Locally Advanced and Metastatic Urothelial Carcinoma
Phase 1/2 Unknown
15 enrolled
A Study Evaluating MM-310 in Patients With Solid Tumors
Phase 1 Unknown
34 enrolled
The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence
Phase 2 Unknown
84 enrolled
FOCUS
Phase 3 Unknown
330 enrolled
iRARC-KSW
Unknown
200 enrolled
PREMIER
Phase 3 Unknown
74 enrolled
BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma
Phase 2 Unknown
129 enrolled
Evaluation Of Zetiq's Novel Cell Detect Technology For Detection Of Bladder Cancer In Urine Cytology
Unknown
500 enrolled
EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells
Unknown
25 enrolled
Tesetaxel for Previously Treated Patients With Bladder Cancer
Phase 2 Unknown
33 enrolled
Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan
Unknown
100 enrolled